Chart: Biotech Stocks - Revenue Per Employee
-
Font Size:
-
Print
- TweetThis
Rob Zenilman submits: Annual gross revenue per employee in the Biotech sector for the most recently reported fiscal year ranged from $1,067,578.90 (GILD) down to $117.30 (TELK), with a median value of $285,206.40
Data in table version -- click on a ticker for opinion and analysis of the company:
| FY | Revenue | ||||
|---|---|---|---|---|---|
| FY | Revenue | # of | Per Employee | ||
| Ticker | Company | Ending | ($mm) | Employees | ($000) |
| AFFX | Affymetrix Inc. | 12/31/05 | $367.60 | 1,101 | $333.88
|
| ALXN | Alexion Pharmaceutic | 12/31/05 | $1.21 | 241 | $5.00
|
| AMGN | Amgen Inc. | 12/31/05 | $12,430.00 | 16,450 | $755.62
|
| AMLN | Amylin Pharmaceutica | 12/31/05 | $140.47 | 1,150 | $122.15
|
| BIIB | Biogen Idec Inc. | 12/31/05 | $2,422.50 | 3,340 | $725.30
|
| BMRN | BioMarin Pharmaceuti | 12/31/05 | $25.67 | 314 | $81.75
|
| BSTE | Biosite Incorporated | 12/31/05 | $287.70 | 1,003 | $286.84
|
| CELG | Celgene Corporation | 12/31/05 | $536.94 | 944 | $568.79
|
| DNA | Genentech Inc. | 12/31/05 | $6,633.37 | 9,500 | $698.25
|
| ELN | Elan Corp. plc | 12/31/05 | $490.30 | 1,729 | $283.57
|
| GILD | Gilead Sciences Inc. | 12/31/05 | $2,028.40 | 1,900 | $1,067.58
|
| GPRO | Gen-Probe Inc. | 12/31/05 | $305.97 | 866 | $353.31
|
| IMCL | Imclone Systems Inc. | 12/31/05 | $383.67 | 991 | $387.16
|
| INCY | Incyte Corp. | 12/31/05 | $7.85 | 177 | $44.33
|
| ISTA | ISTA Pharmaceuticals | 12/31/05 | $10.66 | 161 | $66.21
|
| KOSP | KOS Pharmaceuticals | 12/31/05 | $751.70 | 1,361 | $552.31
|
| MEDI | MedImmune Inc. | 12/31/05 | $1,243.90 | 2,059 | $604.13
|
| NABI | Nabi Biopharmaceutic | 12/31/05 | $108.06 | 776 | $139.25
|
| NBIX | Neurocrine Bioscienc | 12/31/05 | $123.89 | 576 | $215.09
|
| ONXX | Onyx Pharmaceuticals | 12/31/05 | $1.00 | 100 | $10.00
|
| PGNX | Progenics Pharmaceut | 12/31/05 | $9.49 | 149 | $63.66
|
| PHRM | Pharmion Corp. | 12/31/05 | $221.24 | 328 | $674.52
|
| TELK | Telik Inc. | 12/31/05 | $0.02 | 162 | $0.12
|
| VRTX | Vertex Pharmaceutica | 12/31/05 | $160.89 | 810 | $198.63 |
Data: CapitalIQ
Related:
- Most recent opinion and analysis of Biotech stocks
- Full transcripts of recent conference calls in the Biotech sector
- Add the Biotech Stock Blog to your My Yahoo! page
Aside: Did you know that Seeking Alpha now publishes a daily recap of Jim Cramer's Mad Money stock picks?
Related Articles
|

























